The evidence is constructive, but security selection and entry discipline still matter.
65
technical evidence
out of 100
out of 100
Week Ending: 11 September 2026
Brazil BR Healthcare Industry
Biotechnology
For the week ending 11 September 2026, Biotechnology declined 3.33% with 2 advancing, 9 declining, and 2 unchanged constituents. The index is equal weighted and the constituent tape shows uncapped security returns.
Current architecture
Upward Expansion
The activity fan is positively ordered above a rising Trend Line with price accepted above it.
65
technical evidence
Index2476.13
1 week-3.33%
Breadth15%
Members13
Country
🇧🇷 Brazil · BR
Sector
Healthcare
Universe
country-listed
Price basis
Adjusted weekly close
Trend architecture
Index, activity fan and structural anchors
Rolling 156-week evidence. Trend Signal points mark weeks when price, trend and the activity fan confirmed together.
Index Value
Trend Line
Fair Value
Activity Lines
Constructive architecture
Transitional architecture
Defensive architecture
Current architecture
Upward Expansion
4 completed weeks in this state
Trend acceptance
9.6%
Index versus Trend Line
Persistence
100%
Positive across every horizon
Participation
15%
2 advancing, 9 declining
Investor positioning lens
Is the evidence ready for capital?
A rules-based technical classification using trend, breadth, persistence, relative strength and path quality.
Evidence balance
Selective
Five-pillar map
Trend
76
Breadth
33
Persistence
87
Relative
49
Risk quality
89
What supports the view
- The index remains above a constructive Trend gate.
- Constituent trends show positive multi-horizon persistence.
What restrains conviction
- Breadth remains too narrow or inconsistent for a high-conviction position.
- The group is not yet delivering dependable relative outperformance.
- Positive contribution is concentrated in a small leadership cohort.
This is a weekly research classification, not personal investment advice. Sentiment is reported as an independent confirmation layer and does not alter the technical score.
Trend state and durability
Architecture, persistence and constituent regimes
The index path is tested against the underlying security-level trend evidence.
The activity fan is positively ordered above a rising Trend Line with price accepted above it.
State age4 weeks
Trend gateUp
Fan width8.73%
Fast versus slow change3.62 pts
Above 83%
Below 0%
Six completed weeks of price acceptance relative to the full Activity Line fan.
Index persistence
100% agreement
Positive across every horizon
The 13, 26, 39 and 52-week trends all point upward, giving the advance broad horizon agreement.
13-week
17.2%
26-week
12.2%
39-week
7.0%
52-week
20.1%
Constituent trend persistence
92% coverage
Is the index move broadly durable?
75%positive
Coherent positive67%
Coherent negative8%
Average horizon agreement92%
Positive horizon share77%
Weakening positives0
Repairing negatives1
12 constituents measured as of 11 Sep 2026. Median trend age is 18 weeks.
Custom stage map
92% coverage
Where constituents sit in the cycle
42%Stage 2
Stage 1 · Basing33%4 securities
Stage 2 · Advancing42%5 securities
Stage 3 · Distribution8%1 securities
Stage 4 · Declining17%2 securities
Re-acceleration watch0
Transition watch2
Relative strength leaders58%
Fair Value repairs4
Measured as of 11 Sep 2026. Stages summarize price, Activity Line architecture, Fair Value position and relative evidence.
Architecture breadth
73/100 mean confidence
How market energy is distributed
Architecture breadth shows the distribution of expanding, rotating, balancing and contracting securities. It is diagnostic context and is not added as a second vote in the positioning score.
Capital rotation
Performance relative to Healthcare
Relative index
13-week relative trend
Starting level
A rising relative line means this group is compounding faster than Healthcare. A falling line means capital has done better in the parent benchmark.
Relative index98.1
13-week trend96.1
4-week trend change2.81%
Weekly peer rank8 of 10
1 week
-0.8 pts
relative
4 weeks
2.9 pts
relative
13 weeks
9.0 pts
relative
26 weeks
5.1 pts
relative
52 weeks
5.3 pts
relative
Market internals
Participation, dispersion and path risk
Equal-weight index evidence with constituent-level breadth and dispersion.
Breadth
Narrow
Participation quality
15%
advanced
- Advancing
- 2
- Declining
- 9
- Unchanged
- 2
Risk and persistence
52-week lens
Path quality
Annualised weekly volatility20.6%
Drawdown from 52-week high-3.6%
Positive weeks, last 1354%
Current directional run1 week
Turnover versus 13-week norm129%
Breadth impulse-37.2 pts
Cross-section
13 measured
Return distribution
Q1 -5.9%
Median -3.1%
Q3 0.0%
Average winner0.8%
Average loser-5.0%
Dispersion3.3 pts
Top-five upside share100%
Top-five capital share78%
Capital data coverage100%
Dispersion describes how far constituent outcomes are spreading apart. Capital concentration is contextual only; the index itself is equal weighted.
Momentum cycle
30-week persistence
Positive readings show expansion. Negative readings show contraction.
Breadth cycle
Net participation
Advancers less decliners as a percentage of measured constituents.
News and narrative
Does company news confirm the market tape?
Sentiment evidence is still developing
Qualified company-level news coverage is not yet broad enough to influence the group view.
0 qualified records across 13 measured constituents.Leadership tape
Leaders, laggards and contribution shape
Latest completed week, ranked on uncapped constituent returns.
Constituent ledger
Industry constituents
All 13 measured constituents, ranked by latest weekly return.
Rank
Ticker
Company
Exchange
Market cap
Close
Index contribution
Return
The index uses capped equal-weight weekly constituent returns. The ledger shows uncapped security returns so outliers remain visible for research.